We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
Cap. Flow
+$368M
Cap. Flow %
6.41%
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$67M
2
INDA icon
iShares MSCI India ETF
INDA
+$55.1M
3
AAPL icon
Apple
AAPL
+$50.9M
4
INTU icon
Intuit
INTU
+$43.3M
5
LOW icon
Lowe's Companies
LOW
+$41.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.3%
2 Technology 11.38%
3 Healthcare 10.73%
4 Industrials 10.27%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RHI icon
551
Robert Half
RHI
$3.61B
$2.06M 0.04%
37,096
+16,396
+79% +$872K
LBRDK icon
552
Liberty Broadband Class C
LBRDK
$4.15B
$2.05M 0.04%
24,047
+19,244
+401% +$1.71M
RIG icon
553
Transocean
RIG
$5.92B
$2.04M 0.04%
191,156
-217,755
-53% -$2.26M
SLM icon
554
SLM Corp
SLM
$4.58B
$2.03M 0.04%
+179,956
New +$1.97M
WIX icon
555
WIX.com
WIX
$2.15B
$2.03M 0.04%
+35,339
New +$2.19M
EXPD icon
556
Expeditors International
EXPD
$22.9B
$2.03M 0.04%
+31,382
New +$1.92M
NYT icon
557
New York Times
NYT
$11.6B
$2.02M 0.04%
+109,307
New +$2.03M
DIS icon
558
Walt Disney
DIS
$165B
$2.02M 0.04%
18,797
-142,420
-88% -$14.7M
HRTX icon
559
Heron Therapeutics
HRTX
$86.3M
$2.02M 0.04%
111,584
+76,974
+222% +$1.26M
CAVM
560
DELISTED
Cavium, Inc.
CAVM
$2.02M 0.04%
24,065
-14,255
-37% -$1.1M
HES
561
DELISTED
Hess
HES
$2.01M 0.04%
42,400
+80
+0.2% +$3.61K
FINL
562
DELISTED
Finish Line
FINL
$2.01M 0.04%
138,487
+128,181
+1,244% +$1.38M
EXR icon
563
Extra Space Storage
EXR
$31.2B
$1.99M 0.03%
22,739
-3,974
-15% -$335K
FCN icon
564
FTI Consulting
FCN
$4.82B
$1.99M 0.03%
46,281
+37,055
+402% +$1.51M
NSA
565
DELISTED
National Storage Affiliates Trust
NSA
$1.99M 0.03%
72,921
+61,479
+537% +$1.58M
TEX icon
566
Terex
TEX
$7.98B
$1.98M 0.03%
41,012
-24,169
-37% -$1.11M
NE
567
DELISTED
Noble Corporation
NE
$1.98M 0.03%
437,187
+147,405
+51% +$611K
TER icon
568
Teradyne
TER
$54.8B
$1.97M 0.03%
47,090
-184,408
-80% -$7.6M
PODD icon
569
Insulet
PODD
$11.3B
$1.96M 0.03%
28,413
+22,413
+374% +$1.47M
LHCG
570
DELISTED
LHC Group LLC
LHCG
$1.96M 0.03%
+31,930
New +$2.11M
WERN icon
571
Werner Enterprises
WERN
$2.54B
$1.95M 0.03%
+50,531
New +$1.84M
MASI
572
DELISTED
Masimo
MASI
$1.95M 0.03%
22,975
-36,412
-61% -$3.16M
OUT icon
573
Outfront Media
OUT
$5.64B
$1.95M 0.03%
85,210
-25,274
-23% -$592K
HDB icon
574
HDFC Bank
HDB
$119B
$1.93M 0.03%
76,000
-19,016
-20% -$455K
MBI icon
575
MBIA
MBI
$288M
$1.93M 0.03%
263,947
+232,155
+730% +$1.81M

Similar funds

Squarepoint's Q4 2017 Portfolio in Review

As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.

  • Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
  • Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
  • Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
  • Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
  • Squarepoint opened 949 new positions and closed 486 in Q4 2017.
  • Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.

Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.